Momenta Pharmaceuticals (MNTA)

Add to Watchlists
Create an Alert
11.55 +0.00  +0.00% NASDAQ Apr 16, 5:00PM BATS Real time Currency in USD
View Full Chart
MNTA Price Chart
View All Events

MNTA Events

Date Type Description
Feb 10 Misc Momenta Pharmaceuticals Fourth Quarter 2013 Earnings Call
Feb 10 Earnings Momenta Pharmaceuticals, Inc. Q4 2013 Earnings Results. Estimate: -0.45.
Nov 05 Earnings Q3 2013 Earnings. Estimate: -0.48.
Nov 05 Misc Momenta Pharmaceuticals Announces Date of Third Quarter 2013 Financial Results Conference Call and Webcast
Aug 01 Misc Momenta Pharmaceuticals Second Quarter 2013 Earnings Call
Aug 01 Earnings Second Quarter 2013 Financial Results. Estimate: -0.50.
Jun 11 Misc AGM Event for Momenta Pharmaceuticals Inc
Apr 30 Misc Momenta Pharmaceuticals Announces Date of First Quarter 2013 Financial Results Conference Call and Webcast
Apr 30 Earnings Momenta Pharmaceuticals, Inc. First Quarter Earnings Results. Estimate: -0.42.
View All Performance Charts

MNTA Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Momenta Pharmaceuticals is down 11.15% over the last year vs S&P 500 Total Return up 22.52%, Teva Pharmaceutical up 32.62%, and Mylan up 68.01%.

Get Quote for

Pro Report PDF for MNTA

Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download MNTA Pro Report PDF
Advertisement

Pro Strategies Featuring MNTA

Did Momenta Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

MNTA Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Current Fiscal Year End: December 31, 2014
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Momenta Pharmaceuticals, Inc. develops and discovers drugs. The company specializes in the detailed structural analysis of complex mixture drugs. It applies its technology to the development of generic versions of complex drugs and novel drugs. The firm also specializes in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, like heparan-sulfate proteoglycans, or HSPGs. The company was formerly known as Mimeon, Inc. and changed its name to Momenta Pharmaceuticals, Inc. in September 2002. Momenta Pharmaceuticals, Inc. was founded by Ram Sasisekharan and Ganesh Venkatraman in May 2001 and is headquartered in Cambridge, Massachusetts.

Recent Quotes

Symbol Price Chg Chg % Market Cap
MNTA 11.55 +0.00 +0.00% 606.10M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.